2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
about
Echocardiographic findings associated with mortality ortransplant in patients with pulmonary arterial hypertension:A systematic review and meta-analysisVascular Remodelling and Mesenchymal Transition in Systemic SclerosisPulmonary vasculature in COPD: The silent componentPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesAdaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapyRecent advances in the management of pulmonary arterial hypertensionExercise-based rehabilitation programmes for pulmonary hypertension.Special considerations in pregnant systemic sclerosis patients.Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisNovel Analysis of the Oral Treprostinil Combination Therapy Trial Data.Safety of regadenoson stress testing in patients with pulmonary hypertension.Ante-mortem diagnosis of pulmonary tumour thrombotic microangiopathy in a patient with unrecognised extramammary Paget's disease.Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension.Machine Learning of Three-dimensional Right Ventricular Motion Enables Outcome Prediction in Pulmonary Hypertension: A Cardiac MR Imaging Study.Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening methodSERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.Exercise tolerance improves after pulmonary rehabilitation in pulmonary hypertension patientsMolecular and functional characterization of the BMPR2 gene in Pulmonary Arterial HypertensionProstacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure-overloaded human right heartThe Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension.Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fractionA systematic review of transition studies of pulmonary arterial hypertension specific medicationsThe safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challengesThe Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary VasculatureAutomated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension.Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone systemAcute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension.Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images.Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variabilityThe Challenges in Managing Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.Pharmacokinetic interaction study between riociguat and the combined oral contraceptives levonorgestrel and ethinylestradiol in healthy postmenopausal womenCharacterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking.Right atrial contractile dynamics are impaired in patients with postcapillary pulmonary hypertension.Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension
P2860
Q26748865-6786E5D5-AF64-47CC-B35F-7922491105C6Q26749091-8FBA6296-0694-4151-AB51-F6E2DCC6C5DBQ26749309-F11DBC32-3007-4B32-80A6-502423C32AACQ26771309-FDF547EE-9A5C-40FF-8FBF-E06391E4BAB9Q27342609-1C7A96BE-33F7-4345-8047-6404F499AEFDQ28072649-CD62B484-8E73-401F-A544-DB0F50AF60CEQ28075707-F7C10CCB-1D00-4780-B222-90B1D5D89C26Q30238951-2B964F71-CEE4-45DF-804B-A2DB76D0F65DQ30244385-7C2FD7EA-4E2E-49B4-8A01-C66344FB21ECQ30245016-14C31AEE-006D-45A5-8242-009329380746Q30251818-2509D895-07A7-45AA-99D2-765AEC41E683Q31038854-71D0351E-D86F-47D7-A343-A193DB01C1ABQ31108228-5389C27B-8546-4B26-8C76-974B7B3E6903Q33167948-351DF12B-19DD-48FB-B88B-6FD5B5988833Q33434869-69296BF9-11DB-4791-90D9-3CED5CEED660Q33440512-64636AD2-8354-4114-92DB-2DA8E8C83957Q33584006-7E76DEF2-39D3-427C-A1BE-C3803D5CE3FCQ33587163-E85C34D4-B325-42FE-AFA1-E615D43BBD4BQ33589653-35E2EDEB-6295-447A-A820-919F30A1FBC6Q33596457-293A61D8-7BBD-426C-879C-8E9B3119339DQ33625126-5A438E43-FEE0-4076-B57E-6E5E8EF7503DQ33689573-5A2EEC04-B832-457C-B42C-53D011F16CA5Q33788428-132BDE18-671D-43A6-9FDF-B4F7931C49F6Q33788447-3926D294-E356-4880-B3DB-06D9465FEB7BQ33788474-C01FA495-061D-44EA-BFAE-6BA3DF5010D0Q33788548-7E6653D7-576A-4541-B028-8749C41705E8Q33788554-1C9A0B34-00E9-405A-98A7-CD587EAA3E3DQ33788582-ABB9F62D-CAFE-427D-8608-B1B61162776DQ33804336-1A1CDDFE-73CB-4AE6-B3FA-6FBD852D5F87Q36132400-35C5CAD7-AFD2-40CA-AE54-28DBB1201CFCQ36159683-A8CB975D-6429-4B6E-9754-77B0D02034CDQ36190169-C682347E-B7D9-4208-A511-A7081D41E96DQ36292050-1DDB2377-9748-40A7-A9CA-036DF3A77B2EQ36382353-277B9EAC-12F5-40B5-AD91-5E1468A71445Q36721773-859BFA22-13C9-41DE-AFE9-D9D69889E756Q36881728-41013DF0-738E-4543-B248-24A5D370FC1BQ37010939-B16CC409-0289-4649-B5D0-F3BCB1DAE109Q37108790-85598208-EF1B-4304-893B-3762A4BD9090Q37217507-5E4D3248-DEE4-469A-8D9A-AAF296EE1A64Q37248323-DDD0380A-3B8E-4B60-B9B7-27F5976B57C2
P2860
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
description
article
@en
im August 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2015
@uk
name
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
@en
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
@nl
type
label
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
@en
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
@nl
prefLabel
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
@en
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
@nl
P2093
P50
P1476
2015 ESC/ERS Guidelines for th ...... d Lung Transplantation (ISHLT)
@en
P2093
Adam Torbicki
Andrew Peacock
Anton Vonk Noordegraaf
Georg Hansmann
Gérald Simonneau
Irene Lang
Jean-Luc Vachiery
Luc A Pierard
Marco Matucci
Maurice Beghetti
P304
P356
10.1183/13993003.01032-2015
P577
2015-08-29T00:00:00Z